Author: CAPAHC
-
Tenofovir to Prevent Hepatitis B Transmission in Mothers with High Viral Load
Calvin Q. Pan, M.D., Zhongping Duan, M.D., Erhei Dai, M.D., Shuqin Zhang, M.D., Guorong Han, M.D., Yuming Wang, M.D., Huaihong Zhang, M.D., Huaibin Zou, M.D., Baoshen Zhu, M.D., Wenjing Zhao, M.D., and Hongxiu Jiang, M.D., forthe China Study Group for the Mother-to-Child Transmission of Hepatitis B*
-
Hep C tainted blood victims, federal government argue in court over $250M fund
CBC News Posted: Jun 20, 2016 2:50 PM ET Last Updated: Jun 20, 2016 4:19 PM ET ‘Victims are being re-victimized,‘ says man whose wife died before receiving any compensation
-
Governments on Track to Eliminate Viral Hepatitis by 2030
194 Member States commit to eliminating viral hepatitis at World Health Assembly LONDON, May 30, 2016 /CNW/ – On 28 May, 194 Member States made a historic commitment to eliminate viral hepatitis by 2030. At the 69th World Health Assembly, governments unanimously voted to adopt the first ever Global Viral Hepatitis Strategy, signalling the greatest global commitment in…
-
Impact of direct anti-viral agents on inactivation/de-listing of liver transplant candidates listed for decompensated C cirrhosis: a European study
Background and Aims: Preliminary reports indicate that in Liver Transplant candidates listed for Hepatitis C virus (HCV) decompensated cirrhosis, Direct-Acting Antivirals (DAA) therapy may result in liver function improvement. Whether this clinical improvement translates into the delisting of some patients is presently unknown. Therefore, the major object of this study was to assess if and which…
-
Hep C: Expanded treatment access in Quebec
Good news for hepatitis C patients in Quebec: • All patients with chronic hepatitis C, genotype 1 and fibrosis stage F2-F4 will have access to Harvoni and Holkira Pak from March 24, 2016.
-
Next step in hep C treatment: A Gilead pangenotypic treatment
A Gilead pangenotypic treatment (1,2,4,5,6) is coming soon, maybe the end of the genotyping… A simple treatment regimen that is effective in a broad range of patients who are chronically infected with the hepatitis C virus (HCV) remains an unmet medical need.
-
HCV transmission during anal sex may happen without blood, study in HIV/HCV coinfected men finds
Hepatitis C virus is present in large enough quantities in the rectal fluid of men with HIV and hepatitis C co-infection to permit HCV transmission without the presence of blood, researchers from the Icahn School of Medicine, Mount Sinai Hospital, New York, reported on Sunday at the 2015 AASLD Liver Meeting in San Francisco.
-
TECHNIVIE Approved for Genotype 4 Chronic Hepatitis C Infection
TECHNIVIE provides an opportunity to treat adults who have genotype 4 (GT4) chronic hepatitis C virus (HCV) infection without cirrhosis, a population historically considered difficult–to-treat TECHNIVIE is the first and only all-oral, interferon-free, direct-acting antiviral treatment approved in Canada for adult patients with GT4 chronic HCV infection Approval is supported by a Phase II clinical…
-
Tenofovir Helps Prevent Herpes Simplex Virus Type 2 Infection
Originally published in the New England Journey of Medecine Salim S. Abdool Karim, M.B., Ch.B., Ph.D., Quarraisha Abdool Karim, Ph.D., Ayesha B.M. Kharsany, Ph.D., Cheryl Baxter, Ph.D., Anneke C. Grobler, Ph.D., Lise Werner, M.Sc., Angela Kashuba, Pharm.D., Leila E. Mansoor, Ph.D., Natasha Samsunder, B.Tech., Adrian Mindel, M.D., and Tanuja N. Gengiah, Ph.D. for the CAPRISA…
-
Hep C: If you were infected by blood transfusion, between 1986 and 1991
This document could be for you, because the Joint Committee wants to hear from you, about a financial surplus.
